BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 37097212)

  • 21. Mucosal-homing natural killer cells are associated with aging in persons living with HIV.
    Kroll KW; Shah SV; Lucar OA; Premeaux TA; Shikuma CM; Corley MJ; Mosher M; Woolley G; Bowler S; Ndhlovu LC; Reeves RK
    Cell Rep Med; 2022 Oct; 3(10):100773. PubMed ID: 36208628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-Reported Cannabis Use and Markers of Inflammation in Men Who Have Sex With Men With and Without HIV.
    Krsak M; Wada NI; Plankey MW; Kinney GL; Epeldegui M; Okafor CN; Friedman MR; Palella FJ; Erlandson KM
    Cannabis Cannabinoid Res; 2021 Apr; 6(2):165-173. PubMed ID: 33912681
    [No Abstract]   [Full Text] [Related]  

  • 23. Albuminuria is associated with elevated acute phase reactants and proinflammatory markers in HIV-infected patients receiving suppressive combination antiretroviral therapy.
    O-charoen P; Ndhlovu LC; Gangcuangco LM; Keating SM; Norris PJ; Ng RC; Mitchell BI; Shikuma CM; Chow DC
    AIDS Res Hum Retroviruses; 2014 Dec; 30(12):1185-91. PubMed ID: 25205472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression.
    Castillo-Mancilla JR; Brown TT; Erlandson KM; Palella FJ; Gardner EM; Macatangay BJ; Breen EC; Jacobson LP; Anderson PL; Wada NI
    Clin Infect Dis; 2016 Dec; 63(12):1661-1667. PubMed ID: 27660234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Age and HIV Status on Immune Activation, Senescence and Apoptosis.
    Hove-Skovsgaard M; Zhao Y; Tingstedt JL; Hartling HJ; Thudium RF; Benfield T; Afzal S; Nordestgaard B; Ullum H; Gerstoft J; Mocroft A; Nielsen SD
    Front Immunol; 2020; 11():583569. PubMed ID: 33117394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations Between Plasma Immunomodulatory and Inflammatory Mediators With VACS Index Scores Among Older HIV-Infected Adults on Antiretroviral Therapy.
    Premeaux TA; Javandel S; Hosaka KRJ; Greene M; Therrien N; Allen IE; Corley MJ; Valcour VG; Ndhlovu LC
    Front Immunol; 2020; 11():1321. PubMed ID: 32695109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic Inflammation and the Increased Risk of Inflamm-Aging and Age-Associated Diseases in People Living With HIV on Long Term Suppressive Antiretroviral Therapy.
    Babu H; Ambikan AT; Gabriel EE; Svensson Akusjärvi S; Palaniappan AN; Sundaraj V; Mupanni NR; Sperk M; Cheedarla N; Sridhar R; Tripathy SP; Nowak P; Hanna LE; Neogi U
    Front Immunol; 2019; 10():1965. PubMed ID: 31507593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma cytokine profiles in HIV-1 infected patients developing neuropathic symptoms shortly after commencing antiretroviral therapy: a case-control study.
    Van der Watt JJ; Wilkinson KA; Wilkinson RJ; Heckmann JM
    BMC Infect Dis; 2014 Feb; 14():71. PubMed ID: 24512313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic Biomarkers in Peripheral Blood of Persons With Tuberculosis and Advanced HIV.
    Queiroz ATL; Araújo-Pereira M; Barreto-Duarte B; Gomes-Silva A; Costa AG; Andrade AMS; Miguez-Pinto JP; Spener-Gomes R; Souza AB; Benjamin A; Sant'Anna F; Figueiredo MC; Mave V; Salgame P; Ellner JJ; Sterling TR; Cordeiro-Dos-Santos M; Andrade BB; Rolla VC
    Front Immunol; 2022; 13():890003. PubMed ID: 35757685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased Plasma Levels of the TH2 chemokine CCL18 associated with low CD4+ T cell counts in HIV-1-infected Patients with a Suppressed Viral Load.
    Malhotra P; Haslett P; Sherry B; Shepp DH; Barber P; Abshier J; Roy U; Schmidtmayerova H
    Sci Rep; 2019 Apr; 9(1):5963. PubMed ID: 30979916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic performance of blood inflammatory markers for tuberculosis screening in people living with HIV.
    Farr K; Ravindran R; Strnad L; Chang E; Chaisson LH; Yoon C; Worodria W; Andama A; Ayakaka I; Bbosa Nalwanga P; Byanyima P; Kalema N; Kaswabuli S; Katagira W; Aman KD; Musisi E; Tumwine NW; Sanyu I; Ssebunya R; Davis JL; Huang L; Khan IH; Cattamanchi A
    PLoS One; 2018; 13(10):e0206119. PubMed ID: 30352099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations in Abundance and Compartmentalization of miRNAs in Blood Plasma Extracellular Vesicles and Extracellular Condensates during HIV/SIV Infection and Its Modulation by Antiretroviral Therapy (ART) and Delta-9-Tetrahydrocannabinol (Δ
    Kopcho S; McDew-White M; Naushad W; Mohan M; Okeoma CM
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV.
    Merlini E; Cozzi-Lepri A; Castagna A; Costantini A; Caputo SL; Carrara S; Quiros-Roldan E; Ursitti MA; Antinori A; D'Arminio Monforte A; Marchetti G
    BMC Infect Dis; 2021 Jun; 21(1):557. PubMed ID: 34116650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High level of plasma TILRR protein is associated with faster HIV seroconversion.
    Kashem MA; Lischynski J; Stojak B; Li L; Yuan XY; Liang B; Kimani J; Plummer FA; Luo M
    EBioMedicine; 2022 Apr; 78():103955. PubMed ID: 35339895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viremic and Virologically Suppressed HIV Infection Increases Age-Related Changes to Monocyte Activation Equivalent to 12 and 4 Years of Aging, Respectively.
    Angelovich TA; Hearps AC; Maisa A; Martin GE; Lichtfuss GF; Cheng WJ; Palmer CS; Landay AL; Crowe SM; Jaworowski A
    J Acquir Immune Defic Syndr; 2015 May; 69(1):11-7. PubMed ID: 25647525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States.
    Coburn SB; Humes E; Lang R; Stewart C; Hogan BC; Gebo KA; Napravnik S; Edwards JK; Browne LE; Park LS; Justice AC; Gordon KS; Horberg MA; Certa JM; Watson E; Jefferson CR; Silverberg MJ; Skarbinski J; Leyden WA; Williams CF; Althoff KN;
    JAMA Netw Open; 2022 Jun; 5(6):e2215934. PubMed ID: 35671054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-infection plasma cytokines and chemokines as predictors of HIV disease progression.
    Ngcobo S; Molatlhegi RP; Osman F; Ngcapu S; Samsunder N; Garrett NJ; Abdool Karim SS; Abdool Karim Q; McKinnon LR; Sivro A
    Sci Rep; 2022 Feb; 12(1):2437. PubMed ID: 35165387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suicide Ideation and Attempt Among People With HIV: A Statewide Population-level Cohort Analysis Between 2005 and 2020.
    Mi T; Zhang J; Yang X; Chen S; Weissman S; Olatosi B; Li X
    J Acquir Immune Defic Syndr; 2024 Feb; 95(2):117-125. PubMed ID: 37977196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained Viral Suppression With Dolutegravir Monotherapy Over 192 Weeks in Patients Starting Combination Antiretroviral Therapy During Primary Human Immunodeficiency Virus Infection (EARLY-SIMPLIFIED): A Randomized, Controlled, Multi-site, Noninferiority Trial.
    West E; Zeeb M; Grube C; Kuster H; Wanner K; Scheier T; Neumann K; Jörimann L; Hampel B; Metzner KJ; Kouyos RD; Braun DL; Günthard HF
    Clin Infect Dis; 2023 Oct; 77(7):1012-1020. PubMed ID: 37338148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of systemic low-grade inflammation in HIV patients on long-term suppressive antiretroviral therapy: the inflammasome hypothesis.
    Guerville F; Vialemaringe M; Cognet C; Duffau P; Lazaro E; Cazanave C; Bonnet F; Leleux O; Rossignol R; Pinson B; Tumiotto C; Gabriel F; Appay V; Déchanet-Merville J; Wittkop L; Faustin B; Pellegrin I;
    AIDS; 2023 Jun; 37(7):1035-1046. PubMed ID: 36928274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.